Cypherpunk Technologies, Inc. (CYPH)
1.67
-0.04
(-2.34%)
USD |
NASDAQ |
Sep 02, 16:00
1.67
0.00 (0.00%)
After-Hours: 18:41
Cypherpunk Technologies Total Assets (Quarterly) : 142.97M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 142.97M |
| March 31, 2026 | 87.38M |
| December 31, 2025 | 171.80M |
| September 30, 2025 | 11.40M |
| June 30, 2025 | 20.04M |
| March 31, 2025 | 34.88M |
| December 31, 2024 | 49.12M |
| September 30, 2024 | 65.05M |
| June 30, 2024 | 81.43M |
| March 31, 2024 | 57.96M |
| December 31, 2023 | 72.82M |
| September 30, 2023 | 83.05M |
| June 30, 2023 | 95.86M |
| March 31, 2023 | 106.55M |
| December 31, 2022 | 70.35M |
| September 30, 2022 | 82.16M |
| June 30, 2022 | 94.20M |
| March 31, 2022 | 105.90M |
| December 31, 2021 | 117.91M |
| Date | Value |
|---|---|
| September 30, 2021 | 128.08M |
| June 30, 2021 | 37.94M |
| March 31, 2021 | 45.81M |
| December 31, 2020 | 54.37M |
| September 30, 2020 | 60.54M |
| June 30, 2020 | 67.67M |
| March 31, 2020 | 28.74M |
| December 31, 2019 | 7.448M |
| September 30, 2019 | 14.14M |
| June 30, 2019 | 20.14M |
| March 31, 2019 | 26.08M |
| December 31, 2018 | 19.07M |
| September 30, 2018 | 27.13M |
| June 30, 2018 | 34.41M |
| March 31, 2018 | 38.69M |
| December 31, 2017 | 29.06M |
| September 30, 2017 | 17.58M |
| June 30, 2017 | 22.73M |
| March 31, 2017 | 28.78M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Indaptus Therapeutics, Inc. | 11.99M |
| ACADIA Pharmaceuticals, Inc. | 1.743B |
| Alnylam Pharmaceuticals, Inc. | 5.559B |
| Anika Therapeutics, Inc. | 183.47M |
| Savara, Inc. | 192.14M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 3.65M |
| Shareholders Equity (Quarterly) | 139.32M |
| Debt to Equity Ratio | 0.0003 |
| Current Ratio | 79.19 |
| Net Debt Paydown Yield | 0.15% |